IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i6p3279-d768349.html
   My bibliography  Save this article

Diagnostic and Clinical Manifestation Differences of Glucose Transporter Type 1 Deficiency Syndrome in a Family with SLC2A1 Gene Mutation

Author

Listed:
  • Weronika Pawlik

    (Department of Pediatric Hematooncology and Gastroenterology, Pomeranian Medical University, 71-252 Szczecin, Poland)

  • Patrycja Okulewicz

    (Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology, Pomeranian Medical University, 71-252 Szczecin, Poland)

  • Jakub Pawlik

    (Department of Orthopaedics, Traumatology and Orthpaedic Oncology, Pomeranian Medical University, 71-252 Szczecin, Poland)

  • Elżbieta Krzywińska-Zdeb

    (Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology, Pomeranian Medical University, 71-252 Szczecin, Poland)

Abstract

Glucose transporter type 1 deficiency syndrome is a rare genetic disease that manifests neurological symptoms such as mental impairment or movement disorders, mostly seen in pediatric patients. Here, we highlight the main symptoms, diagnostic difficulties, and genetic correlations of this disease based on different clinical presentations between the members of a family carrying the same mutation. In this report, we studied siblings—a 5-year-old girl and a 6-year-old boy—who were admitted to a pediatric ward with various neurological symptoms. Different diagnostic procedures such as lumbar puncture, electroencephalography, and MRI of the brain were performed on these patients. Whole genome sequencing identified mutations in the SLC2A1 and GLUT1-DS genes, following which a ketogenic diet was implemented. This diet modification resulted in a good clinical response. Our case report reveals patients with the same genetic mutations having distinctive clinical manifestations.

Suggested Citation

  • Weronika Pawlik & Patrycja Okulewicz & Jakub Pawlik & Elżbieta Krzywińska-Zdeb, 2022. "Diagnostic and Clinical Manifestation Differences of Glucose Transporter Type 1 Deficiency Syndrome in a Family with SLC2A1 Gene Mutation," IJERPH, MDPI, vol. 19(6), pages 1-7, March.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:6:p:3279-:d:768349
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/6/3279/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/6/3279/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:6:p:3279-:d:768349. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.